1. |
Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin, 2000, 50: 7-33.
|
2. |
Parkin DM, Bray F, Ferlay J, et al. Global Cancer Statistics. CA Cancer J Clin, 2005, 55: 74-108.
|
3. |
Lassen U, Osterlind K, Hansen M, et al. Long-term survival in small-cell lung duration in small cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years. An analysis of 1, 714 consecutive patients. J Clin Oncol, 1995, 13: 1215-1220.
|
4. |
Lassen U, Osterlind K, Hansen M, et al. Long-term survival in smallcell lung cancer: posttreatment characteristics in patients surviving 5 to 18+years. An analysis of 1, 714 consecutive patients. J Clin Oncol, 1995, 13: 1215-1220.
|
5. |
Souhami RL, Bradbury I, Geddes DM, et al. Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung. Cancer Res, 1985, 45: 2878-2882.
|
6. |
Osterlind K, Andersen PK. Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation. Cancer Res, 1986, 46: 4189-4194.
|
7. |
Ar r i a g ada R, Le Che v a l i e r T, Pi gnon JP, e t al . Ini t i a l chemotherapeutic doses and survival in patients with limited smallcell- lung cancer. N Engl J Med, 1993, 329: 1848-1852.
|
8. |
Deglor igio CM, Got t PS, RobininczAL, e t al . Neuron - specificennlase, a marker of acute neuronal injury is increased in complex partial status epilepticus. Epilepsia, 1996, 37(7): 606.
|
9. |
历为良, 钱桂生, 黄桂君, 等. 人肺癌组织细胞Na/H交换蛋白-1基因的表达与其抗凋亡的关系. 中国 癌症杂志, 2000, 10(2): 14.
|
10. |
马兰海. 血清神经元特异性烯醇化酶对小细胞肺癌的诊断价值探讨. 放射免疫学杂志, 2002, 15(6): 351-352.
|
11. |
刘关键, 吴泰相, 康德英. Meta-分析中的统计学过程. 中国临床康复, 2003, 7(4): 538-539.
|
12. |
Johnson PWM, Joel SP, Love S, et al. Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer. Br J Cancer, 1993, 67: 760-766.
|
13. |
JorgensenLGM, Osterlind K, Genolia J, et al. Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC) a combined multivariable analysis on data from nine centres. Br J Cancer, 1996, 74: 463-467.
|
14. |
Quoix E, PurohitM A, Beau F, et al. Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy. Lung Cancer, 2000, 30: 127-134.
|
15. |
Shibayama T, Ueoka H, Nishii K, et al. Complementary roles of progastrin- releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC). Lung Cancer, 2001, 32: 61-69.
|
16. |
金炳文, 赵兰, 周彩存, 等. 神经元特异性烯醇化酶检测在小细胞肺癌预后中的价值. 中华结核和呼吸杂志, 2001, 24(12): 722-724.
|
17. |
Bremnes RM, Sundstrom S, Aasebø U, et al. The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up. Lung Cancer, 2003, 39: 303-313.
|
18. |
Ando S, Suzuki M, Yamamoto N, et al. The prognostic value of both NSE and cyfra21-1 in Small Cell Lung Cancer. Anticancer Res, 2004, 24: 1941-1946.
|
19. |
宋丽华, 宋现让, 张锡芹, 等. 小细胞肺癌患者预后因素分析. 中华肿瘤杂志, 2004, 26(7): 413-416.
|
20. |
刘丽诗, 胡华成. 神经元特异性烯醇化酶、癌胚抗原、乳酸脱氢酶在小细胞肺癌中的预后价值比较. 苏州大学学报(医学版), 2005, 25 (2): 261-264.
|